Congress funds diabetes screening push to catch Type 1 earlier
S. 4612 — SCREEN for Type 1 Diabetes Act of 2026 · Filed by Jeanne Shaheen (D-NH) · 3 cosponsors · Introduced May 20, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the CDC to launch a national public awareness campaign about Type 1 diabetes detection, screening, and management, funded at $5 million annually through 2031. The campaign will produce educational materials, public service announcements, and grant funding to state and local health departments to increase screening rates, with particular focus on communities experiencing rising Type 1 diabetes incidence. The bill requires the CDC to consult with medical organizations, nonprofits, schools, and community groups to ensure culturally appropriate messaging.
Why we flagged it
This bill establishes a CDC-led national awareness and screening campaign for Type 1 diabetes detection, funded through grants to nonprofits and state/local health departments. It is fundamentally a public health education and prevention initiative with no hidden commercial carve-outs or narrow beneficiaries.
What the text implies
- Increased screening rates may expand the diagnosed Type 1 diabetes population, potentially increasing demand for insulin and diabetes management products and services across the healthcare system.
- The campaign's focus on 'communities with the largest significant increases in the incidence of type 1 diabetes' may reveal or amplify awareness of health disparities in specific geographic or demographic groups, which could inform future targeted interventions.
The full analysis lists 3 implications of this text.
Who stands to gain
Nonprofit diabetes advocacy organizations; State and local public health departments; Insulin manufacturers and diabetes device companies